Table 4

Predictors of abstract referral ratings†

Abstract 1
OR
95% CI		Abstract 1
OR
95% CI		Abstract 3
OR
95% CI		Abstract 4
OR
95% CI
High vs low country origin0.85
0.67 to 1.07		0.94
0.75 to 1.19		1.28*
1.02 to 1.62		0.9
0.71 to 1.13
Male (vs female)0.95
0.75 to 1.20		0.78*
0.61 to 0.99		0.98
0.78 to 1.25		0.84
0.66 to 1.06
41–50 years (vs 21–40)0.98
0.72 to 1.34		0.85
0.62 to 1.16		1.06
0.77 to 1.46		0.83
0.61 to 1.15
51–60 years (vs 21–40)0.92
0.67 to 1.28		0.83
0.60 to 1.15		1.15
0.83 to 1.60		0.8
0.58 to 1.11
61+ years (vs 21–40)1.07
0.77 to 1.50		1.09
0.77 to 1.54		1.16
0.83 to 1.63		0.84
0.60 to 1.18
Clinical academic credentials (vs academic only)0.92
0.67 to 1.26		0.75
0.54 to 1.04		0.92
0.66 to 1.28		0.79
0.57 to 1.08
US born (vs not)0.91
0.67 to 1.23		0.8
0.59 to 1.09		0.84
0.61 to 1.14		1.01
0.74 to 1.38
Reads research daily (vs <daily)0.95
0.75 to 1.21		0.97
0.76 to 1.23		0.93
0.74 to 1.19		1.1
0.86 to 1.39
CEPH programme (vs school)1.26
0.98 to 1.62		1.12
0.87 to 1.43		1.11
0.86 to 1.43		1.67***
1.30 to 2.15
Ivy League institution (vs others)0.8
0.52 to 1.24		0.71
0.46 to 1.11		0.92
0.59 to 1.43		0.96
0.62 to 1.49
South region (vs Northeast)0.91
0.65 to 1.29		1.14
0.80 to 1.61		0.93
0.66 to 1.30		1.01
0.72 to 1.43
Midwest region (vs Northeast)1.09
0.73 to 1.63		1.39
0.93 to 2.07		1.04
0.70 to 1.55		1.23
0.83 to 1.84
West region (vs Northeast)1.16
0.74 to 1.82		1.2
0.77 to 1.89		0.88
0.56 to 1.39		0.97
0.62 to 1.52
60–<120 s spent reading (vs <60 s)0.65**
0.50 to 0.84		0.73*
0.55 to 0.96		0.97
0.74 to 1.28		1.31*
1.02 to 1.67
120+ s spent reading (vs <60 s)0.5***
0.35 to 0.72		0.61**
0.44 to 0.84		0.66*
0.47 to 0.93		1.55*
1.01 to 2.38
N‡895895895895

  • *p<0.05; **p<0.01; ***p<0.001.

  • †Generalised ordered logit models controlling for all variables in each column.

  • ‡Only survey responses with no missing data included in the multivariate analysis.

  • Abstract 1, RCT/Service; Abstract 2, Cross-sectional/Service; Abstract 3, RCT/Pharmaceutical; Abstract 4, Cross-sectional/Pharmaceutical.